Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight

New York, USA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight The increasing incidence of respiratory...
September 24, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
September 19, 2024 08:30 ET | Source: Disc Medicine Inc

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer

WATERTOWN, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of...
August 13, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Prader–Willi Syndrome Market is Expected to Showcase Growth at a CAGR of ~6% by 2034 | DelveInsight

New York, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Prader–Willi Syndrome Market is Expected to Showcase Growth at a CAGR of ~6% by 2034 | DelveInsight The Prader–Willi syndrome market is...
August 08, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Global Next-Generation Complement Therapeutics Market to Surge Significantly at a CAGR of ~15% by 2030 | DelveInsight

New York, USA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Global Next-Generation Complement Therapeutics Market to Surge Significantly at a CAGR of ~15% by 2030 | DelveInsight The next-generation...
August 08, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Global Stem Cell Market to Cross ~USD 29 Billion Mark by 2030 | DelveInsight

New York, USA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Global Stem Cell Market to Cross ~USD 29 Billion Mark by 2030 | DelveInsight The stem cell market is experiencing positive growth due to several...
August 06, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Obesity...
July 29, 2024 13:00 ET | Source: DelveInsight Business Research LLP

IDH Inhibitor Market to Exhibit Significant Growth Rate During the Study Period (2020–2034) | DelveInsight

New York, USA, July 29, 2024 (GLOBE NEWSWIRE) -- IDH Inhibitor Market to Exhibit Significant Growth Rate During the Study Period (2020–2034) | DelveInsight The IDH inhibitors market is expected...
July 23, 2024 13:00 ET | Source: DelveInsight Business Research LLP

GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, July 23, 2024 (GLOBE NEWSWIRE) -- GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The...
July 08, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

New York, USA, July 08, 2024 (GLOBE NEWSWIRE) -- Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...